List Labs is a California-based biotherapeutic CDMO that offers a full range of services from early stages to process development to cGMP manufacturing for phase I and II clinical supply. In 2026, List Lab’s purpose-built phase III and commercial manufacturing facility will be operational for cGMP-compliant, large-scale manufacturing.
